Debio-0931

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameDebio-0931
Drug Alias NameCDC25 phosphatase inhibitors (Ipsen/Debiopharm)BN-82002BN-83065IRC-083864
ClassificationSmall molecules
Mechanisms of ActionCell division cycle 25 phosphatase inhibitors
TargetsCell division cycle 25 phosphatase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDebiopharm International SaIpsen SA
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A